We would love to hear your thoughts about our site and services, please take our survey here.
I quite like your Horse racing analogy's Richob, something to lighten the mood especially when Sir Al stubbornly refuses to do that for us
I had a big loss yesterday after backing 'The tedious Wyndrum' who after a slow start went off at a tangent before getting lost in the long grass, last seen going round in circles long after the crowd had lost interest.
Hope to have better success today with:
'Bams update' & 'Where's the effing test'
Non runners today include:
'Turkish PPE'
'Inject the bleach'
'It'll be gone by Easter'
'The unused Nightingale'
Sad thing is Ben it is highly likely that the same disadvantaged people will not receive access to cheap accurate tests.
Arnold, I think we will achieve market leading S&S figures but I'm concerned that the time taken in achieving this will lead to us missing the imminent tender award.
I suppose we have to ask ourselves whether Steve Jobs or Mark Zuckerberg gave a **** about updating their impatient shareholders or just cracked on with making them all very very rich by focussing on creating world leading products regardless of how long it took to do so.
Would you rather:
1. RNS tomorrow announcing that S&S was slightly disappointing and only slightly better than Innova however we have secured £300m of the latest tender due to us being a sovereign supplier.
2. RNS tomorrow stating that S&S was ‘exquisite’ and market leading however due to the extended development time and clinical validation process we have not been ready to submit a test for the latest tender.
I posted here several weeks ago that the principal reason HMG went with Innova was simply because they had a test ready and they were able to supply the volume.
Yes they have stolen first mover advantage and trousered several hundred million of contracts as a result. However, it is becoming increasingly obvious that the test isn’t very good and moreover it is in danger of undermining the whole principle of LFT POC testing, a point regularly rammed home by our friend Mr Deeks.
Absolutely everything still to play for, no missed buses for a high performing sovereign test. If the S&S numbers are good then the only constraint I can see for AVCT is manufacturing capacity and availability of components.
American test ?? Come on Daily Mail, you’ve missed a chance to appeal to your jingoistic readers.
It’s a cheap Chinese test there is nothing American about it.
Amazed they haven’t picked that up so they can run with a story about China sending us the virus then selling us the cure ... blah blah blah
This board has been great today, as it was last weekend (with the exception of the fact that we were at £1.32 last weekend) great to be devoid of brain dead minimum wage derampers.
Like many, I am underwater here and whilst I remain confident, it is sometimes difficult not to succumb to self doubt in the face of concerted deramping.
I am fully aware of the basic emotion that they tap into and I’m fully aware that they don’t have the intellect to provide reasons arguments but their incessant banging away with the same tired talking points RNS, House, etc etc. can occasionally make me question my own judgment, especially when as the share price continues to drift south.
Days like today remind me to revert to the science and when you do that it fills you with a warm glow and confirms that it’s not a question of if only a question of when.
Having said that I do have some reservations which I feel centre around AVCT’s ability to deliver. They have no track record of successful contract delivery, no track record of collaboration with 3rd party manufacturers (BBI/Abingdon/Cytiva).
For me, the science is sound, the question is can AVCT commercialise that science? CV19 has given them that opportunity to do that in spades? Next RNS is absolutely massive.
In a different subject,
Scardey Cat - that movie ‘Free Solo’ is one of the scariest films I’ve ever seen, far more so than any horror movie, I watched it through my fingers. That guy is utterly insane, not for the faint hearted or anyone who doesn’t like heights.
Sure you don’t any to meet me on the pub car park before you go Doh ??
The Monday morning club are so predictable I’m surprised that anyone still bites (only Usain missing this morning)
They are here to exploit post weekend non RNS disappointment to collect a few cheap shares that they can sell on at a profit later in the week.
Only an idiot is unable to see their game, ignore, filter, remember your research and stay patient.
Innova have a great business model - supply tests of appropriately poor quality to require multiple tests need to be taken to achieve an accurate result. Hence HMG are required to buy significantly greater quantities than would be required were the innova test fit for purpose.
I bet the Innova owners are having a right laugh at the expense of the British taxpayer.
‘Dr Susan Hopkins, chief medical adviser to NHS Test and Trace, said the lateral flow tests could identify many cases of infection in people without symptoms.
Speaking to the BBC, she accepted there had been "false negatives" but stressed the policy was a "game-changer".
https://www.bbc.co.uk/news/uk-55198298
4. Mortgagefreeman will come on here moaning about delays and Als new house.
Oke
BBC news at 6 just ran a pretty damning article about the accuracy of LFT testing and their use (or lack of) in the fight against Covid.
Seems clear to me that Innova are damaging the market and undermining confidence in LFT’s in general. We desperately need an accurate test supported by good results and positive press or we will join track and trace and Turkish PPI in the ‘failed HMG initiatives’ column
These guys are just snake~oil salesmen.
It’s one thing ripping people off with ‘miracle’ slimming pills but this is people’s lives they are playing with.
There must be some robust legislation within the medical world that prevents false or misleading claims. The authorities need to get on top of this ASAP or the likes of Deeks and the Guardian will undermine public confidence in POC/Home testing, with some justification.
According to the gov website they conducted 362,000 PCR tests yesterday, extrapolated that’s circa 132 million PA.
The talk is of 500 million LFTs PA UK only. We don’t need to worry about ‘competition’ we need to worry about getting a good test to market. When we do it really is fill your boots time.
‘As JVT would say, it’s 2-2 in the 89th minute and we have just been awarded a penalty.’
Let’s just hope that big Al isn’t the Gareth Southgate of LFT testing ....
You don’t need to be inspector Morse to deduce that this delay is for the benefit of AVCT. We know we are very close and we know HMG wants a sovereign test.
My question would be, s the delay for accreditation/approval or product/technical reasons?
It may well be that the extension isn’t exclusively for the benefit of AVCT but I wouldn’t bet against it.. let’s see if the market agrees.
Agreed AgentB I really enjoy Arnold Ps positivity... he reminds me a lot of Poundcake.... I liked him too, he stopped posting around the time AP joined ........
Not sure if this has any implications for Avct/Affimers??
https://www.bbc.co.uk/news/science-environment-55133972
Agree, Richob
I suspect many holders are currently underwater after buying into the pre-vaccine rise in sentiment. In the absence of any confirmed news it is perhaps understandable that questions and doubts are raised.
What all holders must remind themselves is that the research they undertook remains sound and nothing we have heard should lead any holder to believe that their investment is at any greater risk than when they made the decision to invest. if anything, as time passes logic dictates that risk is mitigated as we would have heard if significant hurdles/problems had been encountered.
For what it is worth, I increased my holding last week at £1.20 as it seems inconceivable to me even that if you discount the obvious opportunities due to missed boats, competition etc, if any of the partnerships you list materialise they each could be incredibly lucrative.
I feel it is short-sighted and illogical to view delays in only a negative light, it does unfortunately seem that the market sees it this way but I suspect there is significant pent up demand waiting for any confirmatory RNS, which depending on the content will see money piling back in.
Having said that, I do feel for holders who perhaps need their money out pre Christmas and having been trapped by the 'fake' vaccine drop can hopefully hang on and reap the rewards that are surely coming.